Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix Safety and Immunogenicity in Lung Transplant Recipients
NCT03493776Phase 4Unknown
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ). Status: unknown.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03493776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03493776.